PROCEPT BioRobotics (PRCT) Total Current Liabilities (2020 - 2025)
PROCEPT BioRobotics has reported Total Current Liabilities over the past 6 years, most recently at $65.8 million for Q4 2025.
- Quarterly results put Total Current Liabilities at $65.8 million for Q4 2025, up 23.83% from a year ago — trailing twelve months through Dec 2025 was $65.8 million (up 23.83% YoY), and the annual figure for FY2025 was $65.8 million, up 23.83%.
- Total Current Liabilities for Q4 2025 was $65.8 million at PROCEPT BioRobotics, up from $53.9 million in the prior quarter.
- Over the last five years, Total Current Liabilities for PRCT hit a ceiling of $65.8 million in Q4 2025 and a floor of $14.2 million in Q3 2021.
- Median Total Current Liabilities over the past 5 years was $40.0 million (2023), compared with a mean of $38.4 million.
- Biggest five-year swings in Total Current Liabilities: skyrocketed 120.26% in 2023 and later increased 0.47% in 2025.
- PROCEPT BioRobotics' Total Current Liabilities stood at $16.2 million in 2021, then soared by 117.28% to $35.3 million in 2022, then skyrocketed by 30.14% to $45.9 million in 2023, then increased by 15.69% to $53.1 million in 2024, then increased by 23.83% to $65.8 million in 2025.
- The last three reported values for Total Current Liabilities were $65.8 million (Q4 2025), $53.9 million (Q3 2025), and $49.7 million (Q2 2025) per Business Quant data.